tiprankstipranks
Trending News
More News >
CanSino Biologics, Inc. Class H (HK:6185)
:6185

Compare CanSino Biologics, Inc. Class H (6185) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CanSino Biologics, Inc. Class H
HK$44.94
HK$13.51B
-57.08
25.54%
1 Buy
0 Hold
0 Sell
Moderate Buy
Guangzhou Baiyunshan Pharmaceutical Holdings Company
HK$18.75
HK$44.07B
9.60
8.58%
Livzon Pharmaceutical Group
HK$30.94
HK$31.92B
11.33
11.57%
Shanghai Fosun Pharmaceutical (Group) Co
HK$19.63
HK$74.73B
15.55
56.12%
2 Buy
0 Hold
0 Sell
Moderate Buy
China Resources Pharmaceutical Group Ltd.
HK$4.61
HK$28.59B
9.40
-13.00%
Hansoh Pharmaceutical Group Company Limited
HK$38.60
HK$233.73B
44.46
115.88%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6185
CanSino Biologics, Inc. Class H
35.34
6.99
24.66%
HK:0874
Guangzhou Baiyunshan Pharmaceutical Holdings Company
18.98
2.02
11.93%
HK:1513
Livzon Pharmaceutical Group
29.40
4.06
16.04%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
20.42
7.81
61.90%
HK:3320
China Resources Pharmaceutical Group Ltd.
4.55
-0.51
-10.08%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.60
21.00
119.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts